Matinas BioPharma
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -74 | 85 | -114 | -124 |
EBITDA | -1,847 | -604 | -2,039 | -5,232 |
EBIT | -1,921 | -1,027 | -2,150 | -5,245 |
Net Income | -1,921 | -1,912 | -2,150 | -5,245 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,601 | -1,509 | -1,474 | -2,021 |
Cash | 2,448 | 3,999 | 5,435 | 6,525 |
Basic Shares | 6,406 | 5,474 | 5,435 | 5,086 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,096 | $3,188 |
Gross Profit | -456 | -972 | 155 | -13,490 |
EBITDA | -9,889 | -19,190 | -22,001 | -20,641 |
EBIT | -10,345 | -20,162 | -22,942 | -20,997 |
Net Income | -10,345 | -24,251 | -22,942 | -20,997 |
Net Change In Cash | 0 | 0 | 1,096 | 3,188 |
Cost of Revenue | -14,200 | |||
Free Cash Flow | -7,011 | -15,885 | -15,496 | -20,048 |
Cash | 3,999 | 7,284 | 4,787 | 6,880 |
Basic Shares | 5,474 | 4,865 | 4,345 | 4,336 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.30 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.40 |
2025-06-30 | -$1.03 |